Journal
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Volume 613, Issue -, Pages 140-145Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbrc.2022.04.142
Keywords
Breast cancer; BRCA1; Estrogen; DNA Damage; Estrogen receptor-alpha
Categories
Funding
- National Key Research and Development Program [2017YFA0102800]
- National Natural Science Foundation of China [31970811, 31771639, 32170798]
- Guangdong Innovative and Entrepreneurial Research Team Program [2016ZT06S029]
- Guangdong Basic and Applied Basic Research Foundation [2021B1515120063]
- Guangdong Regenerative Medicine and Health of Guangdong Laboratory Frontier Exploration Project [2018GZR110105007]
- Natural Science Foundation of Guangdong Province, China [2021A1515010938]
Ask authors/readers for more resources
Estrogen (E2) and BRCA1 deficiency synergistically induce DNA damage in breast cancer cells, possibly involving transcriptional activation of ER genes and changes in DNA damage distribution.
Estrogen (E2) is crucial for the development of breast cancer caused by BRCA1 mutation, and can increase the DNA damage in BRCA1-deficient cells. However, the mechanisms through which BRCA1 deficiency and E2 synergistically induce DNA damage remains unclear. In this study, we analyzed the distribution of DNA damage in E2-treated BRCA1-deficient cells. We detected DNA lesions in the vicinity of genes that are transcriptionally activated by estrogen receptor-alpha (ER). Loss of BRCA1 altered chromatin binding by ER, which significantly affected the distribution of DNA damage. Moreover, these changes were associated with the established mutations in BRCA1-mutant breast cancer. Taken together, our findings reveal a new mechanism underlying the DNA damage in breast cancer cells that is synergistically induced by BRCA1 deficiency and E2. (C) 2022 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available